If you’re new to investing, the stock market can seem daunting. However, you can start investing with only $100. There are a number of ways to do this, such as through a brokerage account, a mutual fund, or a dividend reinvestment plan (DRIP).
Investing in stocks can be a great way to build your wealth over time. When you invest in stocks, you’re essentially buying a piece of a company. As the company grows and becomes more profitable, the value of your stock will increase. If you sell your shares at the right time, you can make a profit.
Of course, there is risk involved in any investment, and the stock market can be volatile. However, if you’re patient and invest for the long term, you can potentially make a lot of money by investing in stocks.
Pinduoduo Inc. ($NASDAQ:PDD) is an innovative e-commerce platform that offers a wide variety of products at extremely low prices. It is one of the largest e-commerce platforms in China and is quickly gaining popularity in other countries as well.
Pinduoduo’s mission is to make shopping fun and affordable for everyone. The company offers a wide variety of products, including clothes, food, and home goods, at extremely low prices. Pinduoduo also offers a unique social shopping experience that allows users to connect with friends and family while they shop.
As one of the fastest-growing e-commerce platforms in the world, the company has grown from a small startup to a multibillion-dollar business in just four years. In 2019, Pinduoduo’s annual sales reached $30 billion.
Pinduoduo is quickly gaining popularity outside of China. The company has launched an international version of its app and is now available in 10 languages. Pinduoduo is also expanding its business into new markets, such as Indonesia and India.
Roku, Inc. ($NASDAQ:ROKU) is a leading streaming platform that delivers entertainment to millions of people around the world. The company offers a variety of streaming devices, including the Roku streaming stick, Roku streaming player, Roku TV, and Roku Ultra. Roku also offers a wide selection of streaming content, including movies, TV shows, music, and games.
Roku is a great pick for investors who are looking for a growth stock with a strong competitive advantage. The company has a wide moat thanks to its large user base and extensive content catalog. Roku also has a strong balance sheet, with no debt and plenty of cash on hand.
Roku shares have been on a tear in recent years, and the stock is up more than 1,000% since its IPO in 2017 at it’s peak. Roku is one of the best-performing stocks in the market, and there is no reason to think that the company’s growth will slow down any time soon.
If you are looking for a high-growth stock with a strong competitive advantage, Roku is a great pick.
DEXCOM ($NASDAQ:DXCM) is a leading medical device company that manufactures and markets continuous glucose monitoring (CGM) systems for people with diabetes. The company’s flagship product, the Dexcom G4 Platinum CGM system, is the only FDA-approved CGM system that does not require fingerstick calibrations. This makes it a highly convenient and accurate choice for people with diabetes who want to closely monitor their blood sugar levels.
The Dexcom G4 Platinum CGM system is used by more than 250,000 people with diabetes worldwide, and the company has a strong track record of delivering innovative products that improve the lives of people with diabetes. In addition to the G4 Platinum system, DEXCOM also offers the Dexcom Share2 remote monitoring system, which allows people with diabetes to share their glucose data with loved ones or healthcare providers.
DEXCOM has a strong financial position, with revenues of $1.93 billion in 2020 and a market capitalization of $10.7 billion. The company’s stock has been on a tear in recent years, rising from $30 per share in early 2020 to its current price of around $70 per share. This reflects investor confidence in DEXCOM’s growth prospects, as the company is well-positioned to benefit from the increasing prevalence of diabetes worldwide.
Diabetes is a growing global epidemic, with an estimated 422 million people affected worldwide. The number of people with diabetes is expected to continue to rise in the coming years, driven by factors such as obesity and an ageing population. This presents a significant opportunity for DEXCOM, as the company’s products are essential for people with diabetes who need to closely monitor their blood sugar levels.
In addition to the opportunity presented by the increasing prevalence of diabetes, DEXCOM is also benefiting from strong demand for its products from both new and existing customers. The company’s products are highly effective and have demonstrated strong clinical results. This is resulting in increased demand from both patients and healthcare providers, which is driving growth for the company.